zabmedvestnikЗабайкальский медицинский вестникTransbaikalian Medical Bulletin1998-6173Читинская государственная медицинская академия10.52485/19986173_2024_4_117zabmedvestnik-360Research ArticleНАУЧНЫЕ ОБЗОРЫSCIENTIFIC REVIEWSКОМОРБИДНОСТЬ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ И ДИСФУНКЦИИ ЩИТОВИДНОЙ ЖЕЛЕЗЫCOMORBIDITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THYROID DYSFUNCTIONПашкевичА. В.PashkevichA. V.

Пашкевич Александр Владимирович,  ассистент кафедры госпитальной терапии и эндокринологии

AuthorID: 1268578

672000, г. Чита, ул. Горького, 39а

Pashkevich A.V., assistant of the Department of Hospital Therapy

AuthorID: 1268578

39а Gorky St., Chita, Russia, 672000

pashkevichalex@mail.ruСеребряковаО. В.SerebryakovaO. V.

Серебрякова Ольга Владимировна, д.м.н., профессор, заведующая кафедрой госпитальной терапии и эндокринологии

AuthorID РИНЦ: 433959

672000, г. Чита, ул. Горького, 39а

Serebryakova O.V., Doctor of medical sciences, Professor, Head of the Department of Hospital Therapy

AuthorID: 433959

39а Gorky St., Chita, Russia, 672000

 

serebryakova_ol@mail.ruФГБОУ ВО «Читинская государственная медицинская академия» Министерства здравоохранения РФРоссияChita State Medical AcademyRussian Federation20242502202504117125Copyright © Пашкевич А.В., Серебрякова О.В., 20252025Пашкевич А.В., Серебрякова О.В.Pashkevich A.V., Serebryakova O.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.zabmedvestnik.ru/jour/article/view/360

Хроническая обструктивная болезнь легких (ХОБЛ) является распространенным заболеванием, связанным с хроническим воспалением, как и многие эндокринологические заболевания, включая дисфункцию щитовидной железы. Пациенты, страдающие от ХОБЛ, имеют более высокий риск развития дисфункции щитовидной железы по сравнению с общей популяцией, что подтверждается эпидемиологическими исследованиями. Данная коморбидность недостаточно хорошо изучена, а её диагностика может вызывать затруднение из-за совместного отягощения и наслоения клинических симптомов, при этом указанное сочетание заболеваний может серьезно ухудшать качество жизни пациентов. Изучение того, как дисфункция щитовидной железы связана с хронической обструктивной болезнью легких, может положительно повлиять на прогноз для пациентов. В обзоре анализируются возможные механизмы и клинические характеристики, возникающие при коморбидном течении ХОБЛ и дисфункции щитовидной железы.

Chronic obstructive pulmonary disease (COPD) and endocrinological conditions, such as thyroid dysfunction, are both associated with chronic inflammation. Epidemiological studies have shown that patients with COPD have a higher risk for developing thyroid dysfunction compared to the general population. This comorbidity has not been well studied, and its diagnosis can be difficult due to the combined burden and layering of clinical symptoms, while this combination of the disease can seriously worsen the quality of life of patients. Understanding the relationship between thyroid dysfunction and COPD can help improve the clinical prognosis in these patients. The review examines the existing links between COPD and thyroid diseases, their mechanisms and clinical features.

хроническая обструктивная болезнь легкихдисфункция щитовидной железыгипотиреозгипертиреозкоморбидностьchronic obstructive pulmonary diseasethyroid dysfunctionhypothyroidismhyperthyroidismcomorbidityReferencesGlobal Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2023 https://goldcopd.orgGlobal Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2023 https://goldcopd.orgPapaioannou O., Karampitsakos T., Barbayianni I., et al. Metabolic Disorders in Chronic Lung Diseases. Front Med (Lausanne). 2018 Jan 18. 4.246. doi: 10.3389/fmed.2017.00246.Papaioannou O., Karampitsakos T., Barbayianni I., et al. Metabolic Disorders in Chronic Lung Diseases. Front Med (Lausanne). 2018 Jan 18. 4.246. doi: 10.3389/fmed.2017.00246.García-Olmos L., Alberquilla A., Ayala V., et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross-sectional study. BMC Fam Pract. 2013 Jan 16. 14.11. doi: 10.1186/1471-2296-14-11.García-Olmos L., Alberquilla A., Ayala V., et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross-sectional study. BMC Fam Pract. 2013 Jan 16. 14.11. doi: 10.1186/1471-2296-14-11.Miłkowska-Dymanowska J., Białas A.J., Laskowska P., et al. Thyroid gland in chronic obstructive pulmonary disease. Adv Respir Med. 2017.85 (1). 28–34. doi: 10.5603/ARM.2017.0006.Miłkowska-Dymanowska J., Białas A.J., Laskowska P., et al. Thyroid gland in chronic obstructive pulmonary disease. Adv Respir Med. 2017.85 (1). 28–34. doi: 10.5603/ARM.2017.0006.Korytina G., Akhmadishina L., Kochetova O., et al. Inflammatory and Immune Response Genes Polymorphisms are Associated with Susceptibility to Chronic Obstructive Pulmonary Disease in Tatars Population from Russia. Biochem Genet. 2016 Aug.54(4).388-412. doi: 10.1007/s10528-016-9726-0.Korytina G., Akhmadishina L., Kochetova O., et al. Inflammatory and Immune Response Genes Polymorphisms are Associated with Susceptibility to Chronic Obstructive Pulmonary Disease in Tatars Population from Russia. Biochem Genet. 2016 Aug.54(4).388-412. doi: 10.1007/s10528-016-9726-0.Stouthard J., Van der Poll T., Endert E., et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab. 1994 Nov. 79 (5).1342-6. doi: 10.1210/jcem.79.5.7962327.Stouthard J., Van der Poll T., Endert E., et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab. 1994 Nov. 79 (5).1342-6. doi: 10.1210/jcem.79.5.7962327.Karadag F., Ozcan H., Karul AB., Yilmaz M., Cildag O. Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease. Respir Med. 2007 Jul.101(7).1439-46. doi: 10.1016/j.rmed.2007.01.016.Karadag F., Ozcan H., Karul AB., Yilmaz M., Cildag O. Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease. Respir Med. 2007 Jul.101(7).1439-46. doi: 10.1016/j.rmed.2007.01.016.McCusker K. Mechanisms of respiratory tissue injury from cigarette smoking. Am J Med. 1992 Jul 15.93(1A).18-21. doi: 10.1016/0002-9343(92)90622-i.McCusker K. Mechanisms of respiratory tissue injury from cigarette smoking. Am J Med. 1992 Jul 15.93(1A).18-21. doi: 10.1016/0002-9343(92)90622-i.Meral I., Arslan A., Him A., Arslan H. Smoking-related Alterations in Serum Levels of Thyroid Hormones and Insulin in Female and Male Students. Altern Ther Health Med. 2015 Sep-Oct. 21 (5). 24–9. PMID: 26393988.Meral I., Arslan A., Him A., Arslan H. Smoking-related Alterations in Serum Levels of Thyroid Hormones and Insulin in Female and Male Students. Altern Ther Health Med. 2015 Sep-Oct. 21 (5). 24–9. PMID: 26393988.Laghi F., Adiguzel N., Tobin M. Endocrinological derangements in COPD. Eur Respir J. 2009 Oct. 34 (4). 975-96. doi: 10.1183/09031936.00103708.Laghi F., Adiguzel N., Tobin M. Endocrinological derangements in COPD. Eur Respir J. 2009 Oct. 34 (4). 975-96. doi: 10.1183/09031936.00103708.Gow S., Seth J., Beckett G., Douglas G. Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease. Thorax. 1987 Jul. 42 (7). 520-5. doi: 10.1136/thx.42.7.520.Gow S., Seth J., Beckett G., Douglas G. Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease. Thorax. 1987 Jul. 42 (7). 520-5. doi: 10.1136/thx.42.7.520.Chaudhary S., Ahmad T., Usman K., et al. Prevalence of thyroid dysfunction in chronic obstructive pulmonary disease patients in a tertiary care center in North India. J Family Med Prim Care. 2018 May- Jun. 7 (3). 584–588. doi: 10.4103/jfmpc.jfmpc_84_17.Chaudhary S., Ahmad T., Usman K., et al. Prevalence of thyroid dysfunction in chronic obstructive pulmonary disease patients in a tertiary care center in North India. J Family Med Prim Care. 2018 May- Jun. 7 (3). 584–588. doi: 10.4103/jfmpc.jfmpc_84_17.Sarinc Ulasli S., Bozbas S., Ozen Z., Ozyurek B., Ulubay G. Effect of thyroid function on COPD exacerbation frequency: a preliminary study. Multidiscip Respir Med. 2013 Oct 1. 8(1). 64. doi: 10.1186/2049-6958-8- 64.Sarinc Ulasli S., Bozbas S., Ozen Z., Ozyurek B., Ulubay G. Effect of thyroid function on COPD exacerbation frequency: a preliminary study. Multidiscip Respir Med. 2013 Oct 1. 8(1). 64. doi: 10.1186/2049-6958-8- 64.Terzano C., Romani S., Paone G., Conti V., Oriolo F. COPD and thyroid dysfunctions. Lung. 2014 Feb.192(1).103-9. doi: 10.1007/s00408-013-9537-6.Terzano C., Romani S., Paone G., Conti V., Oriolo F. COPD and thyroid dysfunctions. Lung. 2014 Feb.192(1).103-9. doi: 10.1007/s00408-013-9537-6.Dimopoulou I., Ilias I., Mastorakos G., et al. Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism. 2001 Dec. 50 (12). 1397-401. doi: 10.1053/meta.2001.28157.Dimopoulou I., Ilias I., Mastorakos G., et al. Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism. 2001 Dec. 50 (12). 1397-401. doi: 10.1053/meta.2001.28157.Bacakoğlu F., Başoğlu O., Gürgün A., et al. Can impairments of thyroid function test affect prognosis in patients with respiratory failure? Tuberk Toraks. 2007.55(4).329-35Bacakoğlu F., Başoğlu O., Gürgün A., et al. Can impairments of thyroid function test affect prognosis in patients with respiratory failure? Tuberk Toraks. 2007.55(4).329-35Miłkowska-Dymanowska J., Białas A., Laskowska P., Górski P., Piotrowski W. Thyroid gland in chronic obstructive pulmonary disease. Adv Respir Med. 2017. 85 (1). 28–34. doi: 10.5603/ARM.2017.0006.Miłkowska-Dymanowska J., Białas A., Laskowska P., Górski P., Piotrowski W. Thyroid gland in chronic obstructive pulmonary disease. Adv Respir Med. 2017. 85 (1). 28–34. doi: 10.5603/ARM.2017.0006.Lee S., Pearce E. Hyperthyroidism: A Review. JAMA. 2023 Oct 17.330(15).1472-1483. doi: 10.1001/jama.2023.19052.Lee S., Pearce E. Hyperthyroidism: A Review. JAMA. 2023 Oct 17.330(15).1472-1483. doi: 10.1001/jama.2023.19052.Agin K., Namavary J. A Survey on Thyroid Hormonal Status among Moderate to Severe Stable Chronic Obstructive Pulmonary Disease. International Journal of Medical Toxicology and Forensic Medicine. 2012. (3). 106–113. https://doi.org/10.22037/ijmtfm.v3i4(Autumn).3643Agin K., Namavary J. A Survey on Thyroid Hormonal Status among Moderate to Severe Stable Chronic Obstructive Pulmonary Disease. International Journal of Medical Toxicology and Forensic Medicine. 2012. (3). 106–113. https://doi.org/10.22037/ijmtfm.v3i4(Autumn).3643Siafakas N., Salesiotou V., Filaditaki V., et al. Respiratory muscle strength in hypothyroidism. Chest. 1992 Jul. 102 (1). 189–94. doi: 10.1378/chest.102.1.189.Siafakas N., Salesiotou V., Filaditaki V., et al. Respiratory muscle strength in hypothyroidism. Chest. 1992 Jul. 102 (1). 189–94. doi: 10.1378/chest.102.1.189.Pino-García J., García-Río F., Díez J., et al. Regulation of breathing in hyperthyroidism: relationship to hormonal and metabolic changes. Eur Respir J. 1998Aug.12(2).400-7. doi: 10.1183/09031936.98.12020400.Pino-García J., García-Río F., Díez J., et al. Regulation of breathing in hyperthyroidism: relationship to hormonal and metabolic changes. Eur Respir J. 1998Aug.12(2).400-7. doi: 10.1183/09031936.98.12020400.Siafakas N., Milona I., Salesiotou V., et al. Respiratory muscle strength in hyperthyroidism before and after treatment. Am Rev Respir Dis. 1992 Oct.146(4).1025-9. doi: 10.1164/ajrccm/146.4.1025.Siafakas N., Milona I., Salesiotou V., et al. Respiratory muscle strength in hyperthyroidism before and after treatment. Am Rev Respir Dis. 1992 Oct.146(4).1025-9. doi: 10.1164/ajrccm/146.4.1025.Luo Y., Zhou L., Li Y, Guo S., et al. Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD. Respir Care. 2016 May.61(5).680-8. doi: 10.4187/respcare.04358.Luo Y., Zhou L., Li Y, Guo S., et al. Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD. Respir Care. 2016 May.61(5).680-8. doi: 10.4187/respcare.04358.Uzun K., Atalay H., Inal A. Thyroid hormon levels in patients with acute exacerbation of chronic obstructive pulmonary disease. Eur J Gen Med. 2007.4. 80–82.Uzun K., Atalay H., Inal A. Thyroid hormon levels in patients with acute exacerbation of chronic obstructive pulmonary disease. Eur J Gen Med. 2007.4. 80–82.El-Yazed H., El-Bassiony M., Eldaboosy S., et al. Assessment of thyroid functions in patients with chronic obstructive pulmonary disease. Egyptian Journal of Chest Diseases and Tuberculosis. 2013. 62(3). 387– 391. doi: 10.1016/j.ejcdt.2013.07.009El-Yazed H., El-Bassiony M., Eldaboosy S., et al. Assessment of thyroid functions in patients with chronic obstructive pulmonary disease. Egyptian Journal of Chest Diseases and Tuberculosis. 2013. 62(3). 387– 391. doi: 10.1016/j.ejcdt.2013.07.009Akpınar E. An underestimated comorbidity of COPD: Thyroid dysfunction. Tuberk Toraks. 2019 Jun. 67 (2). 131–135. doi: 10.5578/tt.68257.Akpınar E. An underestimated comorbidity of COPD: Thyroid dysfunction. Tuberk Toraks. 2019 Jun. 67 (2). 131–135. doi: 10.5578/tt.68257.Yasar Z., Kirakli C., Cimen P., et al. Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients? Int J Clin Exp Med. 2015 Jun 15.8(6).10114-21.Yasar Z., Kirakli C., Cimen P., et al. Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients? Int J Clin Exp Med. 2015 Jun 15.8(6).10114-21.Mancini A., Corbo G., Gaballo A, et al. Relationship between plasma antioxidants and thyroid hormones in chronic obstructive pulmonary disease. Exp Clin Endocrinol Diabetes. 2012 Nov.120(10).623-8. doi: 10.1055/s-0032-1323808.Mancini A., Corbo G., Gaballo A, et al. Relationship between plasma antioxidants and thyroid hormones in chronic obstructive pulmonary disease. Exp Clin Endocrinol Diabetes. 2012 Nov.120(10).623-8. doi: 10.1055/s-0032-1323808.

The authors declare that there are no conflicts of interest present.